Oncology Data Advisor® · Payment Reform Through the Enhancing Oncology Model With Lalan Wilfong, MD At the recent American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Oncology Data Advisor sat down for a conversation with Dr. Lalan Wilfong, the Senior Vice President of Payer and Care Transformation for the US Oncology ...

Oncology Data Advisor® · Finding Real-World Response End Points in NSCLC Data Sets With Janet Espirito, PharmD At the recent American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Janet Espirito, PharmD, a Senior Medical Director at Ontada, sat down with Oncology Data Advisor to discuss her presentation on identifying real-world end points for assessing response in patients receiving novel therapies for metastatic non–small cell lung cancer (NSCLC) outside of clinical trials.  

Oncology Data Advisor® · Coaching Cancer Survivors Through Digital Health: Robin Lally, PhD, and Marilyn Hammer, PhD At the recent American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Oncology Data Advisor sat down for a conversation with Robin Lally, PhD, and Marilyn Hammer, PhD, co–Principal Investigators of the COAC...

At the recent American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Oncology Data Advisor sat down for a conversation with Robin Lally, PhD, and Marilyn Hammer, PhD, co–Principal Investigators of the COACH (Comprehensive Outcomes for After-Cancer Health) study. Dr. Lally and Dr. Hammer share the background of this study and how it is seeking to improve the cancer survivorship experience through digital health interventions and patient-reported outcomes.  

Oncology Data Advisor® · Understanding Sexual Orientation and Gender Identity Data Collection: Mandi Pratt-Chapman, PhD At the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Mandi Pratt-Chapman, Associate Center Director for Community Outreach, Engagement, and Equity at George Washington University Cancer Center, sat down with Oncology Data Advisor to discuss her abstract on difference-making conditions associated with sexual orientation and gender identity (SOGI) data collection among ASCO members' institutions. Dr. Pratt-Chapman gives additional insight into the importance of SOGI data collection for providing patient-centered care and shares advice for instituting data collection processes in order to help guide clinical decision making for LGBTQIA+ patients.  

Oncology Data Advisor® · Molecular Analyses of Sacituzumab Govitecan in Urothelial Carcinoma With Manoj Bupathi, MD At the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Oncology Data Advisor sat down with Manojkumar Bupathi, MD, MS, a Genitourinary (GU) Medical Oncologist at Sarah Cannon Research Institute and Rocky M...

Oncology Data Advisor® · Reducing Cost of Cancer Care Through Novel Therapy Adjustment With Erica Feinberg, PharmD At the recent 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Oncology Data Advisor sat down with Erica Feinberg, PharmD, BCPS, a Senior Clinical Data Analyst at The US Oncology Network, to discuss her post...

Oncology Data Advisor® · Expert Perspectives in the Management of Triple-Negative Breast Cancer:Webinar Preview, Sara Tolaney i3 Health recently hostedPathology and Oncology Expert Perspectives in the Management of Triple-Negative Breast Cancer (TNBC): Case Explorations and Answers to FAQs, an accredited CME/NCPD webinar now available on...

Oncology Data Advisor® · Navigating the Fellowship Experience by Creating Opportunities in Oncology With Waqas Haque In this Oncology Data Advisor® Fellows Forum interview, member Waqas Haque, MD, an Internal Medicine Resident at New York University, shares his medical training journey, the research he has conducted as Clinical Investiga...

i3 Health recently hosted Pathology and Oncology Expert Perspectives in the Management of Triple-Negative Breast Cancer (TNBC): Case Explorations and Answers to FAQs, an accredited CME/NCPD webinar now available on the i3 Health website. In this video interview, Dr. Tolaney shares a preview of the important topics discussed in the activity, includi...

Oncology Data Advisor® · Partnering With Patients Through Advocacy With Allison Rosen At the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Oncology Data Advisor sat down with Allison Rosen, a colorectal cancer survivor, patient advocate, and Director of Project ECHO for the American Cancer Society. Ms. Rosen shares th...

At the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Oncology Data Advisor sat down with Allison Rosen, a colorectal cancer survivor, patient advocate, and Director of Project ECHO for the American Cancer Society. Ms. Rosen shares the story of her cancer journey, how she became involved in patient advocacy, and how to strives to use her platform to bridge the gap between clinical research and cancer patients and survivors.  

Oncology Data Advisor® · The Value of Integrated Palliative Care Training During Fellowship With Richa Thakur, MD In this Oncology Data Advisor® Fellows Forum interview, Richa Thakur, MD, Hematology/Oncology Fellow at Northwell Health, speaks with Nida Khan, MD, a third-year Internal Medicine Resident who is beginning a joint Medical Oncology and Palliative Care Fellowship this July. Dr. Khan discusses the unique opportunities provided by this new type of fellowship, her passions for palliative care and global health, and advice for navigating the fellowship application process to find your niche in the program that is the best fit for you.  

Oncology Data Advisor® · Results of the HERIZON-BTC-01 Trial of Zanidatamab in Biliary Tract Cancers With Shubham Pant, MD At the recent American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Shubham Pant, Associate Professor in the Department of Medical Oncology at MD Anderson Cancer Center, presented the results of HERIZON-BTC-01, a phase 2b trial investigating zanidatamab in previously treated human epidermal growth factor receptor 2 (HER2)–amplified biliary tract cancers. Afterwards he spoke with Oncology Data Advisor to share more about the efficacy, safety, and future directions for zanidatamab. 

Oncology Data Advisor® · Trastuzumab Deruxtecan Safety on HER2 Expressing Solid Tumors With Funda Meric-Bernstam, MD At the recent 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Funda Meric-Bernstam, the Department Chair in the Department of Vascular Cancer Therapeutics at MD Anderson Cancer Center, sat down with O...

This Oncology Data Advisor® Fellows Forum Interview features Dr. Samuel Kareff, Hematology/Oncology Chief Fellow at the University of Miami Sylvester Comprehensive Cancer Center, in discussion with Dr. Ana Velazquez Mañana, an Assistant Professor of Medicine in the Division of Hematology-Oncology at the University of California, San Francisco (UCSF), regarding the unique challenges faced by hematology/oncology trainees during the COVID-19 pandemic. Dr. Velazquez Mañana outlines the impacts on clinical training, research, and career development, as well as the positive changes that have been incorporated into the landscape for hematology/oncology trainees.  

Oncology Data Advisor® · Exciting New Directions for Oncology Data Advisor: Live From ASCO 2023 With Dr.Thomas Abrams At the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Dr. Thomas Abrams, Editor in Chief of Oncology Data Advisor, previewed some of the latest updates on Oncology Data Advisor and the new di...

At the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Dr. Thomas Abrams, Editor in Chief of Oncology Data Advisor, previewed some of the latest updates on Oncology Data Advisor and the new directions that will be taken in 2023, including new ways of partnering with patients to strengthen the patient voice and ultimately improve quality of care.  

Oncology Data Advisor® · Understanding and Improving Quality of Life for Cancer Patients Through Nursing Research Following the recent 48th Oncology Nursing Society (ONS), Terri Armstrong, the Senior Investigator and Deputy Chief of the Neuro-Oncology Branch at the National Institutes of Health (NIH), sat down with Oncology Data Advisor®...

At the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Oncology Data Advisor® had the privilege of interviewing many distinguished physician, nurse, pharmacist, pathologist, and patient advocate speakers about their work and research. These exclusive video and podcast playlists feature more than 30 conversations on a range of topics in oncology treatment and patient care, including the following: